The DTRA was launched in 2020 with the goal of making clinical trial participation widely accessible by advancing policies, research practices, and new technologies in decentralized clinical research. Decentralized approaches to conducting research facilitate participation across broader regions and improve access for more diverse patient populations, the company stated.

Trial to test oral bacteria protein against cancer
The U.S. Food and Drug Administration has given a Rutgers School of Dental Medicine researcher the green light to treat cancer patients with a new kind...

IAG to host webinar on trial imaging for accelerated drug development
Image Analysis Group (IAG) will host a webinar on Friday, May 21 at noon EST on how modern clinical trial infrastructure, including artificial intelligence...

Iqvia debuts clinical data analytics intelligence platform
Iqvia has debuted a clinical data analytics intelligence platform to accelerate vaccine development and drug discovery.

StemExpress to open new facility in Nev.
Medical research firm StemExpress announced that it plans to open a new facility in Reno, NV.

Science 37 launches CRO program for decentralized clinical trials
Science 37 has launched a partnership program called Science 37 Certified, which is designed to empower contract research organizations (CROs) with access,...